English

Español

Pусский

Français

Deutsch

简体中文

Old Website
Total PCR Solution
About Us
  • Who We Are
  • What We Do
  • Our History
  • R&D Capabilities
Product Center
  • System
    • Nucleic Acid Extraction Solution
    • Workstation
    • Real-time PCR System
  • Assay
    • Respiratory Infectious Diseases
    • Cervical Cancer Screening
    • Sexually Transmitted Diseases
    • Vector-Borne Diseases
    • Gastrointestinal Infectious Diseases
    • Zoonotic Infectious Diseases
    • Life Science
Media Center
  • News
  • Events
Service Network
  • Service Offering
  • e-Support
Careers
Contact Us
News Center
to grab latest progress of the company and industry
Bioperfectus Jointly Cooperate with FIND to Accelerate the COVID-19 Self-testing Capacity in LMICs

Bioperfectus, one of the leading in-vitro diagnostics providers for infectious diseases, has partnered with FIND, the global alliance for diagnostics, to lift the COVID-19 self-testing capacity in low- and middle-income countries (LMICs).

2022-02-24 Read more
For A Shared Future, Bioperfectus Story with Sierra Leone

Bioperfectus Nucleic Acid Extraction System SSNP-3000A arrived at Sierra Leone-China Friendship Biological Safety Laboratory (SLE-CHN Biosafety Lab) during the Chinese New Year Festival.

2022-02-16 Read more
Market Approval for Bioperfectus COVID-19 Self-test in Portugal

Aprovação de Mercado para o Autoteste de Covid-19 de Bioperfectus em Portugal

2022-02-09 Read more
Bioperfectus COVID-19 Ag Self-test Approval in Italy

Approvazione di Bioperfectus autotest per l’antigene COVID-19 in Italia

2022-02-08 Read more
Registration Updates: Bioperfectus COVID-19 Self Ag Test is Now Available in Spain

Bioperfectus today solemnly announce that Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test) has been entered in the electronic registry of the Agencia Española de Medicamentos y Productos Sanitarios (Spanish Agency for Medicines and Health Products, AEMPS).

2022-02-05 Read more
Bioperfectus COVID-19 Antigen Self-Testing is now officially included in Austrian Certified Listing

Bioperfectus SARS-CoV-2 Antigen Self-Testing is now officially included in Austrian Certified SARS-CoV-2 Antigen Rapid Tests Listing.

2022-01-28 Read more
Bioperfectus Mass Distribution of Rapid COVID-19 Tests in Israel Begins

The demand for rapid tests is expected to go up after the government announced that the mandatory quarantine period for Israelis infected with COVID-19 would be shortened from a week to five days on January 17th, 2022.

2022-01-27 Read more
Cervical Cancer Awareness Month 2022

Cervical cancer starts in the cells lining the cervix -- the lower part of the uterus (womb). The cervix connects the body of the uterus (the upper part where a fetus grows) to the vagina (birth canal).

2022-01-24 Read more
Bioperfectus 2021 Special Review: Goodbye 2021, Hello 2022

2021 has been an exceptional year for Bioperfectus. We have successfully achieved many milestones by supplying our molecular diagnostic products to where people need them most. The glorious stories and moments shaped 2021 of Bioperfectus, now come and follow us for our special #2021Review.

2021-12-31 Read more
Bioperfectus Obtained CE Mark for the SARS-CoV-2 Antigen Rapid Self-test

Bioperfectus is pleased to announce that we have obtained CE Mark for our Novel Corona Virus (SARS-CoV-2) Ag Rapid Test Kit (Self-test).

2021-12-28 Read more
HomePrev12345678910...NextEnd
  • About Us
  • Who We Are
  • What We Do
  • Our History
  • R&D Capabilities
  • Product Center
  • System
  • Assay
  • Media Center
  • News
  • Events
  • Service Network
  • Service Offering
  • e-Support
  • Careers
  • Contact Us
  • Total PCR Solution
Follow Us

Copyright © 2010-2022 Jiangsu Bioperfectus Technologies Co., Ltd All Rights Reserved.

Tel: +86 021-5484 7326 Email: info@bioperfectus.com